Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31199 total
Dynatrace dropped 26% over the past week to close at $47.03 on November 3, the steepest decline among its closest software peers, with fiscal second-quarter results due the following morning now the single reference…
Mirum Pharmaceuticals reported earnings on November 3 and walked away with a fresh wave of analyst upgrades the following morning, making the Street's response to the print the most interesting thing on the tape this…
CrowdStrike fell 8.7% over the past week to close at $244.68, reversing a large portion of the rally that had briefly pushed it above the analyst consensus target less than two weeks ago, but the cybersecurity sector…
IDEAYA Biosciences heads into the post-earnings week with options traders at their most defensive in months, analysts trimming targets while keeping buy ratings, and a stock down 16% in a month that is still trading at…
PSTL has just printed earnings, and the short position has grown rather than retreated, raising the question of whether bears see more to come or are simply slow to cover. Short interest moved decisively this week. At…
UBER gained 1.2% over the past week to $66.60, outperforming the median of its closest peers, which slipped around 1.5% over the same stretch. That relative resilience is the more striking fact given the Q3 earnings…
Target Hospitality Corp. enters the week of its earnings release with short sellers quietly rebuilding positions, even as the stock bounced 6.5% on Tuesday to close at $14.49. Short interest now represents 3.7% of the…
Fox Corporation reported first-quarter fiscal 2027 results on November 4, and the reaction has wrong-footed a crowded short position: the stock closed at $67.10, up 6.9% on the day and 4.0% on the week, while short…
SNPE, the Xtrackers S&P 500 Scored & Screened ETF, has seen its lending market shift abruptly this week, with short interest doubling and borrow availability collapsing to levels not seen in months. The most striking…
ARES enters the first full post-earnings week at $128.93, up 5.5% on the week but down 3% on the final session, with options traders now the most defensively positioned they have been all year. The standout signal this…
MRNA gained 9.8% over the past week to close at $228.44, a move that stands sharply against a median decline of 3.1% across its closest peers, with ARCT down 15% and CYPH off 17% in the same period. The timing matters:…
RVLV reported its latest quarter on November 3 and the market's reaction was immediate and unwelcome, with the stock down nearly 5% on the week to $21.53 and analysts scrambling to trim their price targets the…
Keurig Dr Pepper is carrying its highest short position in at least a year, with roughly 84.5 million shares sold short, equal to 6.2% of the free float, even as a cluster of analysts raised their price targets on the…
Bloom Energy added 9% on Tuesday to close at $214, but the stock remains 26% below where it traded a month ago, and the central tension has not changed: a broad analyst consensus that the stock is worth $280 to $335…
XLC, the Communication Services Select Sector SPDR ETF, is telling a different story this week: the short rebuild flagged in the previous note has reversed, with covering outpacing the ETF's own modest recovery. Short…
Amneal Pharmaceuticals dropped 5.7% over the past week to close at $20.21, while the median of its closest peers gained 0.8%. The stock is now almost exactly where it started the year, and short sellers have been…
Equitable Holdings has cleared its Q3 earnings hurdle with a 2.6% gain on the day, and the focus has shifted back to where it was before the print: the Corebridge deal and what it means for index weighting across half…
AIQ, the Global X Artificial Intelligence & Technology ETF, enters the first week of November having shed more than 10% over the past month, with options positioning quietly shifting more defensive even as the…
Denali Therapeutics gained 1.2% over the past week while its closest biotech peers fell a median 3.9%, a gap that makes Wednesday's Q3 print the clearest near-term test of whether that relative strength holds. The most…
The story for USMC, the Principal U.S. Mega-Cap ETF, is one of a lending market that swung dramatically tighter through October and has now meaningfully eased, against a backdrop of modest and retreating short…
